Joshua Bakke, MD
Dermatology · Knoxville, TNNPI 1851747695
Payments from drug & device makers
Across 112 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$663
- Regeneron Healthcare Solutions, Inc.$299
- E.r. Squibb & Sons, L.L.C.$164
- Novartis$146
- Sun Pharmaceutical Industries Inc.$94
- Pfizer$60
- plus $486 from 16 others
What the payments were for
- Food & beverage$1,89099%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $663 |
| Regeneron Healthcare Solutions, Inc. | 12 | $299 |
| E.r. Squibb & Sons, L.L.C. | 7 | $164 |
| Novartis | 9 | $146 |
| Sun Pharmaceutical Industries Inc. | 5 | $94 |
| Pfizer | 4 | $60 |
| Johnson & Johnson | 3 | $59 |
| Amgen | 3 | $56 |
| Incyte Corporation | 3 | $54 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
| LEO Pharma Inc. | 2 | $45 |
| Lilly USA, LLC | 3 | $41 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $30 |
| Sanofi | 1 | $21 |
| Cipher Pharmaceuticals US LLC | 1 | $21 |
| UCB, Inc. | 1 | $19 |
| EPI Health, LLC | 1 | $18 |
| Blueprint Medicines Corporation | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Biofrontera Inc. | 1 | $13 |
How this compares
$1,912 in reported general payments places this provider in the 40th percentile of 209 dermatology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 27 | $102,548 |
| Cosentyx Unoready PenSecukinumab | 11 | $79,732 |
| Dupixent SyringeDupilumab | 11 | $41,216 |
| Clobetasol Propionate | 132 | $5,902 |
| Fluorouracil | 62 | $4,092 |
| Tacrolimus | 26 | $3,589 |
| Mycophenolate Mofetil | 17 | $3,540 |
| Betamethasone Dipropionate | 93 | $2,721 |
| Mometasone Furoate | 104 | $2,241 |
| Triamcinolone Acetonide | 197 | $2,054 |
| Ketoconazole | 136 | $1,933 |
| Doxycycline Hyclate | 73 | $1,214 |
| Mupirocin | 151 | $1,205 |
| Metronidazole | 16 | $1,040 |
| Ciclopirox | 35 | $817 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Knoxville
- Kimberly GrandeKnoxville$847K
- Edward PrimkaKnoxville$251K
- Matthew DoppeltKnoxville$36K
- Carley FowlerKnoxville$27K
- Meredith OverholtKnoxville$21K
- Robert GriffithKnoxville$14K
- Robert GriffithKnoxville$14K
- Brittany WareKnoxville$10K
- Michael GoldNashville$5.5M
- Christina FeserClarksville$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.